Antibody-dependent cellular cytotoxicity to clinical isolates of HIV-1 and SIV(cpz): Comparison of humans and chimpanzees

AIDS

Volumn 10, Issue 11, 1996, Pages 1199-1204

  Broliden, Kristina ^a   Hinkula, Jorma ^a   Tolfvenstam, Thomas ^a   Niphuis, Henk ^b   Heeney, Jonathan ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Antibody dependent cellular cytotoxicity; Chimpanzees; HIV 1; Protective immunity; SIV(cpz)

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ANIMAL EXPERIMENT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CHIMPANZEE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKEMIA CELL LINE; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION;

EID: 0029792802     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199609000-00004     Document Type: Article

References (25)

1. Heeney J, Jonker R, Koornstra W, et al.: The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol 1993, 22:194-200.
2. Heeney J: A disease of impaired T-helper (Th)-cell renewal? Immunol Today 1995, 16:515-520.
3. ten Haaft PJF, Cornelissen M, Goudsmit J, et al.: Virus load in human immunodeficiency virus type 1-infected chimpanzees: effect of pre-exposure vaccination. J Gen Virol 1995, 76:1015-1020.
4. Eichberg JW, Zarling JM, Alter HJ, et al.: T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. J Virol 1987, 61:3804-3808.
5. Zarling JM, Ledbetter JA, Sias J, et al.: HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. J Immunol 1990, 144:2992-2998.
6. Belo M, Yagello M, Girard M, et al.: Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees. AIDS 1991, 5:169-176.
7. Lyerly K, Redfield R, Arthur L, et al.: Ontogeny and specificity of ADCC following HIV-1 infection. IV International AIDS Conference. Stockholm, June 1988 [abstract 2178].
8. Ferrari G, Place CA, Ahearne PM, et al.: Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees. J Acquir Immune Defic Syndr 1994, 7:325-331.
9. Niedrig M, Gregersen JP, Fultz PN, Bröker M, Mehdi S, Hilfenhaus J: Immune response of chimpanzees after immunization with the inactivated whole immunodeficiency virus (HIV-1), three different adjuvants and challenge. Vaccine 1993, 11:67-74.
10. Ljunggren K, Biberfeld G, Jondal M, Fenyö EM: Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates. J Virol 1989, 63:3376-3381.
11. Wahren B, Bratt G, Persson C, et al.: Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160. J Acquir Immune Defic Syndr 1994, 7:220-229.
12. Bruck C, Thiriart C, Fabry I, et al.: HIV-1 envelope elicited neutralizing antibody titers correlate with protection and virus load in chimpanzees. Vaccine 1994, 12:1141-1148.
13. Peeters M, Fransen K, Delaporte E, et al.: Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS 1992, 6:447-451.
14. Kestens L, Vingerhoets J, Vanham G, et al.: Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired immunodeficiency virus (SIV cpz-ant) infection. J Infect Dis 1995, 172:957-963.
15. Peeters M, Janssens W, van den Haesevelde M, et al.: Virologic and serologic characteristics of a natural chimpanzee lentivirus infection. Virology 1995, 211:312-315.
16. Rosen CA, Sodroski JG, Campbell K, Haseltine WA: Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes. J Virol 1986, 57:379-384.
17. Sundqvist VA, Albert J, Ohlsson E, Hinkula J, Fenyö EM, Wahren B: HIV-1 p24 antigen variation in tissue culture of isolates with defined growth characteristics. J Virol 1989, 29:170-175.
18. Gotch F, Broliden K: HIV-1-specific cytotoxic T lymphocyte and ADCC responses. In HIV, A Practical Approach, Virology and Immunology, Vol 1. Edited by Karn J. Oxford: Oxford University Press; 1995:253-271.
19. von Gegerfelt A, Nilsson C, Putkonen P, Broliden K: Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys. Vaccine 1994, 12:1203-1208.
20. Koup RA, Pikora CA, Mazzara G, Panicali D, Sullivan JL: Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection. Viral Immunol 1991, 4:215-223.
21. Bolognesi DP: Natural immunity to HIV and its possible relationship to vaccine strategies. Microbiol Sci 1988, 5:236-241.
22. Albert J, Abrahamsson B, Nagy K, et al.:. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990, 4:107-112.
23. Von Gegerfelt A, Albert J, Morfeldt-Månson L, Broliden K, Fenyö EM: Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease. Virology 1991, 185:162-168.
24. Wrin T, Crawford L, Sawyer L, Weber P, Sheppard HW, Hanson CV: Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr 1994, 7:211-219.
25. Ljunggren K, Fenyö EM, Biberfeld G, Jondal M: Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity in vitro. J Immunol Methods 1987, 104:7-14.